Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial

Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:24:01.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-04-24T01:07:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding a study on brexanolone for Acute Respiratory Distress Syndrome (ARDS) related to COVID-19, including detailed inclusion and exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    13%
    Check dated 2025-04-16T20:30:08.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    1%
    Check dated 2025-04-09T14:13:43.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-03-11T08:00:47.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:11:51.000Z thumbnail image

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.